Department of Nutrition, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
J Clin Endocrinol Metab. 2019 Dec 1;104(12):6003-6016. doi: 10.1210/jc.2019-00734.
Subclinical and clinical complications emerge early in type 1 diabetes (T1D) and may be associated with obesity and hyperglycemia.
Test how longitudinal "weight-glycemia" phenotypes increase susceptibility to different patterns of early/subclinical complications among youth with T1D.
SEARCH for Diabetes in Youth observational study.
Population-based cohort.
Youth with T1D (n = 570) diagnosed 2002 to 2006 or 2008.
Participants were clustered based on longitudinal body mass index z score and HbA1c from a baseline visit and 5+ year follow-up visit (mean diabetes duration: 1.4 ± 0.4 years and 8.2 ± 1.9 years, respectively). Logistic regression modeling tested cluster associations with seven early/subclinical diabetes complications at follow-up, adjusting for sex, race/ethnicity, age, and duration.
Four longitudinal weight-glycemia clusters were identified: The Referent Cluster (n = 195, 34.3%), the Hyperglycemia Only Cluster (n = 53, 9.3%), the Elevated Weight Only Cluster (n = 206, 36.1%), and the Elevated Weight With Increasing Hyperglycemia (EWH) Cluster (n = 115, 20.2%). Compared with the Referent Cluster, the Hyperglycemia Only Cluster had elevated odds of dyslipidemia [adjusted odds ratio (aOR) 2.22, 95% CI: 1.15 to 4.29], retinopathy (aOR 9.98, 95% CI: 2.49 to 40.0), and diabetic kidney disease (DKD) (aOR 4.16, 95% CI: 1.37 to 12.62). The EWH Cluster had elevated odds of hypertension (aOR 2.18, 95% CI: 1.19 to 4.00), dyslipidemia (aOR 2.36, 95% CI: 1.41 to 3.95), arterial stiffness (aOR 2.46, 95% CI: 1.09 to 5.53), retinopathy (aOR 5.11, 95% CI: 1.34 to 19.46), and DKD (aOR 3.43, 95% CI: 1.29 to 9.11).
Weight-glycemia phenotypes show different patterns of complications, particularly markers of subclinical macrovascular disease, even in the first decade of T1D.
1 型糖尿病(T1D)早期会出现亚临床和临床并发症,这些并发症可能与肥胖和高血糖有关。
研究纵向“体重-血糖”表型如何增加青少年 T1D 出现不同早期/亚临床并发症模式的易感性。
在青年糖尿病研究(SEARCH)中进行观察性研究。
基于人群的队列。
2002 年至 2006 年或 2008 年确诊的 T1D 青少年(n=570)。
根据基线访视和 5 年以上随访访视时的纵向体重指数 z 评分和糖化血红蛋白(HbA1c)对参与者进行聚类(平均糖尿病病程:1.4±0.4 年和 8.2±1.9 年)。使用逻辑回归模型检验聚类与随访时 7 种早期/亚临床糖尿病并发症之间的关联,调整性别、种族/民族、年龄和病程。
确定了 4 种纵向体重-血糖聚类:参考聚类(n=195,34.3%)、高血糖仅聚类(n=53,9.3%)、单纯超重聚类(n=206,36.1%)和超重伴逐渐升高的高血糖(EWH)聚类(n=115,20.2%)。与参考聚类相比,高血糖仅聚类发生血脂异常的几率更高[校正比值比(aOR)2.22,95%可信区间:1.15 至 4.29]、视网膜病变(aOR 9.98,95%可信区间:2.49 至 40.0)和糖尿病肾病(DKD)(aOR 4.16,95%可信区间:1.37 至 12.62)。EWH 聚类发生高血压的几率更高[aOR 2.18,95%可信区间:1.19 至 4.00]、血脂异常的几率更高[aOR 2.36,95%可信区间:1.41 至 3.95]、动脉僵硬度的几率更高[aOR 2.46,95%可信区间:1.09 至 5.53]、视网膜病变的几率更高[aOR 5.11,95%可信区间:1.34 至 19.46]和 DKD(aOR 3.43,95%可信区间:1.29 至 9.11)。
即使在 T1D 的第一个十年,体重-血糖表型也显示出不同的并发症模式,特别是亚临床大血管疾病的标志物。